Results from a Phase II Single Arm Trial Evaluating the Safety and Efficacy of Anhydrous Enol-Oxaloacetate on Improving Cognitive Complaints in Breast Cancer Survivors. uri icon

authors

  • Ganz, Patricia A
  • Van Dyk, Kathleen
  • Crespi, Catherine M
  • Petersen, Laura
  • Mina S. Sedrak, MD, MS
  • Bower, Julienne E

publication date

  • October 20, 2026